Connor, Clark & Lunn Investment Management Ltd. - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 67 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$64,000
+68.4%
162,043
+377.8%
0.00%
Q1 2022$38,000
-72.5%
33,917
-64.0%
0.00%
-100.0%
Q4 2021$138,00094,2820.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Partner Investment Management, L.P. 308,730$4,481,0003.43%
EcoR1 Capital, LLC 967,114$15,754,0001.42%
NF Trinity Capital (Hong Kong) Ltd 608,060$9,905,0001.31%
PFM Health Sciences, LP 829,868$12,572,0000.18%
Baillie Gifford 3,803,014$61,951,0000.07%
Artal Group S.A. 50,000$815,0000.02%
AllSquare Wealth Management LLC 556$9,0000.01%
FMR LLC 3,562,723$56,232,0000.01%
Capital World Investors 1,035,000$16,860,0000.00%
GILDER GAGNON HOWE & CO LLC 20,000$326,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders